Adamis Pharmaceuticals Corporation

  • ID: 4244572
  • Company Profile
  • 30 pages
  • Dquester
  • Adamis Pharmaceuticals Corporation
1 of 3
Adamis Pharmaceuticals Corporation is a specialty biopharmaceutical company focused on developing and commercializing pharmaceutical products in the therapeutic areas of respiratory disease and allergy. With the rising costs of healthcare in recent years, Adamis aims to make treatments more affordable by creating low-cost therapeutic alternatives. It focuses on large markets for growing its business. In April 2017, Adamis announced public offering of its common stock. It intends to use the net proceeds for general corporate purposes, such as expenditures on research, among others. The company has seen volatility in the last few months.

Adamis is believed to be a key beneficiary of President Trump's pledge on drug pricing and FDA approval process as the President wants the drug prices to come down significantly for the sake of patients and government assistance programs. Adamis is developing and trying to commercialize a lower cost alternative to the EpiPen, the Epinephrine Pre-Filled Syringe. The company has tried twice to win U.S. approval for its epinephrine pre-filled syringe, but regulators have rejected both applications.

Adamis resubmitted to the FDA in December 2016 and the agency has accepted to review the modified application which addresses the issues raised by the FDA in the agency’s June 2016 Complete Response Letter (“CRL”). Analysts believe that Adamis’ product boasts a number of features that could enable it steal market share from EpiPen. Adamis was founded in 2006 and is headquartered in San Diego, California.

Whether Adamis Pharmaceuticals Corporation is your investment target, a potential business partner, a business prospect, a supplier or a rival - this Company Quest Report packages all the key aspects from which Adamis Pharmaceuticals Corporation can be looked at. Vital details related to the company’s operations, history, growth strategy, financial performance, and competitive position are thoroughly studied and captured in this report, along with a SWOT analysis.
READ MORE
Note: Product cover images may vary from those shown
2 of 3

1. COMPANY OVERVIEW

  • Business summary
  • Products and services
  • Growth history/key milestones
  • Ownership and management
  • Recent developments

2. BUSINESS DETAILS

  • Business segment details
  • Subsidiaries and affiliates
  • Alliances and partnerships

3. STRATEGY

  • Growth strategy
  • M&A history

4. FINANCIAL AND OPERATIONAL PERFORMANCE

  • Company performance - last 5 years and last 5 quarters
  • Segmental performance - last 5 years and last 5 quarters
  • Trading performance

5. COMPETITIVE LANDSCAPE

  • Key competitors
  • Market share/positioning
  • Summary profiles/service comparison of key competitors
  • Comparative stock chart
  • Comparison of market cap, sales & profitability growth with peers

6. SWOT ANALYSIS

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll